Finance

Lists
524372:BOM
Orchid Pharma Ltd
၉၁၉.၈၅ ₹
-၀.၆၈%
(-၆.၃၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၀၉:၃၄:၁၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
၉၂၈.၄၀ ₹
High
၉၄၀.၆၅ ₹
Low
၉၁၈.၆၀ ₹
Mkt. cap
ဋေ ၅.၅၀ ထ
Avg. vol.
၆.၈၂ ထောင်
Volume
၉၇၁.၀၀
52-wk high
၁,၁၄၂.၆၅ ₹
52-wk low
၄၇၁.၃၀ ₹
No. of employees
၁ ထောင်
Open
၉၂၈.၄၀ ₹
High
၉၄၀.၆၅ ₹
Low
၉၁၈.၆၀ ₹
Mkt. cap
ဋေ ၅.၅၀ ထ
Avg. vol.
၆.၈၂ ထောင်
Volume
၉၇၁.၀၀
52-wk high
၁,၁၄၂.၆၅ ₹
52-wk low
၄၇၁.၃၀ ₹
No. of employees
၁ ထောင်
News stories
From web sources and news partners
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၅၉ မိနစ်
Dow jumps 556 pts while Nvidia keeps bleeding, our AI spotted the pivot weeks ago
Foreign Policy Journal
Foreign Policy Journal
·
ပြီးခဲ့သည့် ၁ နာရီ
Trump Media (NASDAQ: DJT) And Rumble (NASDAQ: RUM) Stock Tumble 5% After September Inflation Tops Forecasts
HDFC Sky
HDFC Sky
·
ပြီးခဲ့သည့် ၁ နာရီ
US Stock Market Today: Dow, S&P 500 and Nasdaq Close
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees၁.၁၇ ထောင်
Founded၁၉၉၂
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၉၃.၅၂ ဋေ
၂၀၇.၂၇ ဋေ
၆၅၉.၀၆ ဋေ
၃၀၄.၁၇ ဋေ
Cost of goods sold
၁၃၂.၅၁ ဋေ
၁၄၃.၁၅ ဋေ
၅၀၂.၉၀ ဋေ
၂၀၄.၃၀ ဋေ
Cost of revenue
၁၃၂.၅၁ ဋေ
၁၄၃.၁၅ ဋေ
၅၀၂.၉၀ ဋေ
၂၀၄.၃၀ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၄.၈၅ ကုဋေ
၂၄.၁၃ ကုဋေ
၅၀.၂၃ ကုဋေ
၂၈.၀၄ ကုဋေ
Operating expense
၇၁.၃၉ ကုဋေ
၇၁.၅၉ ကုဋေ
၁၃၉.၇၈ ဋေ
၉၆.၈၂ ကုဋေ
Total operating expenses
၂၀၃.၉၀ ဋေ
၂၁၄.၇၃ ဋေ
၆၄၂.၆၈ ဋေ
၃၀၁.၁၂ ဋေ
Operating income
-၁၀.၃၈ ကုဋေ
-၇.၄၇ ကုဋေ
၁၆.၃၈ ကုဋေ
၃.၀၅ ကုဋေ
Other non operating income
၁၀.၇၇ ကုဋေ
၅.၆၁ ကုဋေ
-၂၃.၈၀ ကုဋေ
၁.၈၃ ကုဋေ
EBT including unusual items
-၅.၇၂ ကုဋေ
-၁၂.၆၁ ကုဋေ
၁၃.၁၉ ကုဋေ
၃.၃၀ ကုဋေ
EBT excluding unusual items
-၅.၇၂ ကုဋေ
-၅.၅၀ ကုဋေ
၅.၄၉ ကုဋေ
၃.၃၀ ကုဋေ
Income tax expense
-
-
၁.၇၀ သောင်း
၇.၂၃ သိန်း
Effective tax rate
-
-
၀.၀၁%
၂.၁၉%
Other operating expenses
၃၇.၆၄ ကုဋေ
၃၈.၄၃ ကုဋေ
၄၁.၉၃ ကုဋေ
၅၇.၈၃ ကုဋေ
Net income
-၅.၇၂ ကုဋေ
-၁၂.၆၁ ကုဋေ
၁၃.၁၉ ကုဋေ
၃.၂၂ ကုဋေ
Net profit margin
-၂.၉၆%
-၆.၀၉%
၂.၀၀%
၁.၀၆%
Earnings per share
-၁.၁၃
-၁.၀၈
၄.၅၈
၀.၅၄
Interest and investment income
-
-
၁၀.၁၂ ကုဋေ
-
Interest expense
-၃.၇၃ ကုဋေ
-၃.၁၈ ကုဋေ
-
-၂.၂၃ ကုဋေ
Net interest expenses
-၃.၇၃ ကုဋေ
-၃.၁၈ ကုဋေ
၁၀.၁၂ ကုဋေ
-၂.၂၃ ကုဋေ
Depreciation and amortization charges
၈.၉၀ ကုဋေ
၉.၀၃ ကုဋေ
၁၆.၆၆ ကုဋေ
၁၀.၉၅ ကုဋေ
EBITDA
-၁.၆၀ ကုဋေ
၁.၀၅ ကုဋေ
၂၆.၉၆ ကုဋေ
၁၁.၉၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ